Journal
ANNALS OF NEUROLOGY
Volume 69, Issue 2, Pages 292-302Publisher
WILEY
DOI: 10.1002/ana.22366
Keywords
-
Categories
Funding
- US National Multiple Sclerosis Society (NMSS)
- European Committee for Treatment and Research in Multiple Sclerosis
- Multiple Sclerosis International Federation
- MS Ireland
- Biogen Idec
- Bayer Schering
- Teva
- Merck-Serono
- Novartis
- Glaxo SK
- UCB
- Demos Medical Publishers (New York, NY)
- Multiple Sclerosis Society of Canada
- Canadian Institutes of Health Research
- Biogen Elan
- Merck Serono
- Sanofi-Aventis
- Department of Defense
- NIH
- US NMSS
- Waterfront Media
- ECTRIMS
- MSIF
- Bayer-Schering
- Biogen-Dompe AG
- Genmab A/S
- Teva Pharmaceutical Industries Ltd
- Fondazione Italiana Sclerosi Multipla
- Fondazione Mariani
- Bayer Schering Pharma
- Genmab
- Asahi Kasei Kuraray Medical Co Ltd
- Chemo-Sero-Therapeutic Research Institute
- Mitsubishi Tanabe Pharma
- Teijin Pharma
- Theva Pharmaceutical
- Eisai Inc
- Kowa Pharmaceutical
- Ministry of Education, Science, and Technology of Japan
- Ministry of Health, Labor, and Welfare of Japan
- Astellas Pharma
- Bayer Healthcare
- Health Research Board Ireland
- National Research Foundation Switzerland
- Rubatto Foundation
- Swiss MS society
- European Union
- Roche Foundation
- Novartis Foundation
- NMSS
- Acorda
- Genzyme
- EMD Serono
- EMD Merck Serono
- Genentech
- Almirall
- Bayer Health Care
- Serono Symposia International Foundation
- Swedish Bank SEB
- National Institute for Health Research
- Serono Symposia
- MS International Federation
- Clayton Foundation for Research
Ask authors/readers for more resources
New evidence and consensus has led to further revision of the McDonald Criteria for diagnosis of multiple sclerosis. The use of imaging for demonstration of dissemination of central nervous system lesions in space and time has been simplified, and in some circumstances dissemination in space and time can be established by a single scan. These revisions simplify the Criteria, preserve their diagnostic sensitivity and specificity, address their applicability across populations, and may allow earlier diagnosis and more uniform and widespread use. ANN NEUROL 2011;69:292-302
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
